首页> 外文期刊>Population health management >Incidence Rate of Prediabetes Progression to Diabetes: Modeling an Optimum Target Group for Intervention
【24h】

Incidence Rate of Prediabetes Progression to Diabetes: Modeling an Optimum Target Group for Intervention

机译:糖尿病前期进展为糖尿病的发生率:建模最佳干预目标群体

获取原文
获取原文并翻译 | 示例
           

摘要

Thirty-seven percent of US adults have prediabetes. Various interventions can delay diabetes progression; however, the optimum target group for risk reduction is uncertain. This study estimated rate of progression to diabetes at 1 and 5 years among a cohort of patients from 3 primary care clinics and modeled the potential magnitude in diabetes incidence risk reduction of an intervention program among specific subgroups. Records of 106,821 empaneled patients in 2005 were reviewed. Generalized population attributable risk (PAR) statistics were calculated to estimate the impact of reducing fasting blood glucose on diabetes progression. Multiple intervention effects (varying levels of glucose reduction along with multiple adherence rates) were examined for those with baseline glucose from 110 to 119 mg/dL and >= 120 mg/dL. Ten percent of patients (n = 10,796) met criteria for prediabetes. The 1- and 5-year diabetes incidence rate was 38.6 and 40.24 per 1000 person-years, respectively. Age and obesity were independent predictors of increased progression rate. The generalized PAR for a 10-point reduction in the 110-119 mg/dL subgroup with 25% adherence was 7.6%. The generalized PAR for similar percent reduction and adherence level in patients with baseline glucose of >= 120 mg/dL was only 3.0%. Rate of progression to diabetes increased over time and with associated independent risk factors. Greater risk reduction in diabetes progression within the target population can be achieved when the intervention is successful in those with baseline glucose of 110-119 mg/dL. Modeling an optimum target group for a diabetes prevention intervention offers a novel and useful guide to planning and allocating resources in population health management.
机译:美国成年人中有37%患有糖尿病。各种干预措施可以延迟糖尿病的进展;但是,降低风险的最佳目标人群尚不确定。这项研究估计了来自3家初级保健诊所的一组患者中1年和5年的糖尿病进展速度,并模拟了特定亚组中降低干预措施的糖尿病发生风险的潜在幅度。回顾了2005年记录的106,821名患者。计算了广义人群归因风险(PAR)统计数据,以估算降低空腹血糖对糖尿病进展的影响。对于基线血糖为110至119 mg / dL且> = 120 mg / dL的患者,检查了多种干预效果(葡萄糖降低的水平以及多种依从率)。百分之十的患者(n = 10,796)符合糖尿病前标准。糖尿病的1年和5年发病率分别是每1000人年38.6和40.24。年龄和肥胖是进展速度增加的独立预测因子。对于110-119 mg / dL亚组,依从性为25%的情况,降低10点的广义PAR为7.6%。对于基线葡萄糖> = 120 mg / dL的患者,相似的减少百分比和依从性水平的广义PAR仅为3.0%。随着时间的流逝以及相关的独立危险因素,糖尿病的进展速度增加。当基线血糖为110-119 mg / dL的人群成功干预后,可以在目标人群中更大程度地降低糖尿病进展风险。对糖尿病预防干预措施的最佳目标人群进行建模,为规划和分配人群健康管理资源提供了新颖而有用的指南。

著录项

  • 来源
    《Population health management》 |2017年第3期|216-223|共8页
  • 作者单位

    Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, 200 First St SW, Rochester, MN 55905 USA|Mayo Clin, Dept Med, Div Primary Care Internal Med, Rochester, MN USA;

    Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN USA;

    Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, 200 First St SW, Rochester, MN 55905 USA|Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA;

    Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA;

    Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA;

    Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, 200 First St SW, Rochester, MN 55905 USA|Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号